Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice-Reference-Cited by-同舟云学术

Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice

Published:2022-06 Issue: Volume:Volume 18 Page:1175-1193
ISSN:1178-2021
Container-title:Neuropsychiatric Disease and Treatment
language:en
Short-container-title:NDT

Author:

Chauhan Mohit^ORCID,Parry Rebecca,Bobo William V

Publisher

Informa UK Limited

Reference96 articles.

1. World Health Organization. Depression. Fact sheet No. 369; 2012. Available from: www.who.int.medicentre/factsheets/fs369/en/. Accessed October 25, 2015.

2. The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)

3. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

4. Major depressive disorder: new clinical, neurobiological, and treatment perspectives

5. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative management of medications for psychiatric disorders;Panminerva Medica;2024-09

2. Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response;International Journal of Molecular Sciences;2024-08-29

3. Exploring adverse events of Vilazodone: evidence from the FAERS database;BMC Psychiatry;2024-05-16

4. Structural pharmacology and therapeutic potential of 5-methoxytryptamines;Nature;2024-05-08

5. A Synthetic Approach to Synthesize Furan‐2‐Carboxylate Derivatives by Using a Magnetic Sodium Aluminate Catalyst;ChemistrySelect;2024-05-06